EBVALLO
Live / Applied — Fifth extension granted (statement of use) (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 08 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97355111
- Mark type
- Design + words
- Filed
- 08 Apr 2022
- Published for opposition
- 03 Jan 2023
- Attorney of record
- Lynne Boisineau
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, including, cancer, virus-associated disease and autoimmune disease, including multiple sclerosis, systemic lupus erythematosus and diabetes
Owner
- Atara Biotherapeutics, Inc., Thousand Oaks, CA, US
- Atara Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 16 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2025 — SOU EXTENSION 5 GRANTED
- 10 Jul 2025 — SOU EXTENSION 5 FILED
- 15 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2025 — SOU EXTENSION 4 GRANTED
- 28 Jan 2025 — SOU EXTENSION 4 FILED
- 27 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED